Wyszukiwarka
Abstrakt
Polands's pharmaceutical industry is of great significance to the whole economy. According to Forbs (2 October 2012), the cost of launching a new drug varies from USD 1 to 11 bilion. There is little Chance of a Polish pharmaceutical company developing an original drug due to financial reason.Many research teams in Poland take up research projects aimed at new biologically active compounds. But such an objective has no broader perspective, because the Polish pharmaceutical industry lacks sufficient resources for tests and the registration and promotion of the original drug;. Therefore, such projects will remain purely academic. If commercialized, the result may be, at best, selling the patent rights to a large foreign company for a relatively small amount of money. That is why Polish manufacturers reach for cheaper equivalents of original drugs - generics.
Autor (1)
Cytuj jako
Pełna treść
pełna treść publikacji nie jest dostępna w portalu
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
Polish Market
strony 34 - 35,
ISSN: 1427-0978 - Język:
- angielski
- Rok wydania:
- 2015
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 92 razy